Printer Friendly

HEARTLAND ADVISORS RAISES ITS STAKE IN AEQUITRON MEDICAL

 HEARTLAND ADVISORS RAISES ITS STAKE IN AEQUITRON MEDICAL
 MINNEAPOLIS, Jan. 28 /PRNewswire/ -- Heartland Advisors, a


Milwaukee-based investment management firm, announced today that it recently raised its stake in Aequitron Medical, Inc. (NASDAQ: AQTN) with the purchase of 186,500 shares of the company's stock. Heartland now has 525,900 shares of Aequitron stock in the Heartland Value Fund and in managed accounts. This represents 11 percent of Aequitron's outstanding common shares.
 William Nasgovitz, president of Heartland Advisors, said the purchase was made for investment purposes only. "We believe Aequitron is considerably undervalued at the present time and offers great investment potential," Nasgovitz said.
 Aequitron Medical, Inc. designs, manufactures and markets electronic products for home health care and hospital use; and wheelchair lifts and automobile hand controls for the mobility impaired. The company's common stock is traded on the National Market System under the NASDAQ symbol AQTN.
 -0- 01/28/92
 /CONTACT: Dave Neuger, 612-699-6730 (home), or Ed Neuger, 612-929-0945 (home), both of Edwin Neuger & Associates, 612-333-6621, for Aequitron Medical/
 (AQTN) CO: Aequitron Medical, Inc. ST: Minnesota IN: MTC SU:


KH -- MN009 -- 4202 01/28/92 11:32 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 28, 1992
Words:188
Previous Article:DATATRONIX FINANCIAL SERVICES REPORTS 1991 RESULTS
Next Article:AVERAGE ELECTRIC CUSTOMER USAGE GROWS 16 PERCENT IN 10 YEARS, REPORTS CONSUMERS POWER
Topics:


Related Articles
AEQUITRON MEDICAL CHALLENGES CLASS ACTION SUIT INVOLVING APNEA MONITOR
AEQUITRON MEDICAL APPOINTS DIRECTORS OF SALES AND MARKETING
AEQUITRON MEDICAL ANNOUNCES MARKET RELEASE OF NEW GENERATION OXYGEN CONCENTRATOR
CLASS ACTION SUIT AGAINST AEQUITRON DISMISSED
AEQUITRON MEDICAL ANNOUNCES EARNINGS INCREASE IN FIRST QUARTER
AEQUITRON MEDICAL EXITS UNPROFITABLE OXYGEN CONCENTRATOR PRODUCT LINE; COMPANY EXPECTS TO ANNOUNCE LOSS FOR FIRST QUARTER
AEQUITRON MEDICAL ANNOUNCES AGREEMENT WITH ONE OF NATION'S LARGEST HOME HEALTH CARE PROVIDERS
AEQUITRON MEDICAL ANNOUNCES STOCK REPURCHASE PROGRAM
AEQUITRON MEDICAL NAMES VICE PRESIDENT OF RESEARCH & DEVELOPMENT
NELLCOR PURITAN BENNETT TO ACQUIRE AEQUITRON IN $61 MILLION TRANSACTION

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters